1: Chatzopoulos D, Kyrgidis A, Kountouras J, Zavos C, Molyvas E, Venizelos I. Bax upregulation may provide a rationale for the low incidence of esophageal adenocarcinoma in a Greek cohort of patients with Barrett’s esophagus. Hepatogastroenterology. 2007 Apr-May;54(75):705-9. PMID: 17591046.
2: Ntona S, Papaefthymiou A, Kountouras J, Gialamprinou D, Kotronis G, Boziki M, Polyzos SA, Tzitiridou M, Chatzopoulos D, Thavayogarajah T, Gkolia I, Ntonas G, Vardaka E, Doulberis M. Impact of nonalcoholic fatty liver disease-related metabolic state on depression. Neurochem Int. 2023 Feb;163:105484. doi: 10.1016/j.neuint.2023.105484. Epub 2023 Jan 10. PMID: 36634820.
3: Doulberis M, Papaefthymiou A, Polyzos SA, Vardaka E, Tzitiridou-Chatzopoulou M, Chatzopoulos D, Koffas A, Papadopoulos V, Kyrailidi F, Kountouras J. Local and systemic autoimmune manifestations linked to hepatitis A infection. Acta Gastroenterol Belg. 2023 Jul-Sep;86(3):429-436. doi: 10.51821/86.3.11299. PMID: 37814559.
4: Kountouras J, Kazakos E, Polyzos SA, Papaefthymiou A, Zavos C, Tzitiridou- Chatzopoulou M, Chatzopoulos D, Vardaka E, Gatopoulou A, Kyrailidi F, Mouratidou MC, Doulberis M. Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease. Clin Immunol. 2023 Nov;256:109776. doi: 10.1016/j.clim.2023.109776. Epub 2023 Sep 22. PMID: 37742792.
5: Kountouras J, Tzitiridou-Chatzopoulou M, Papaefthymiou A, Chatzopoulos D, Doulberis M. COVID-19 mRNA Vaccine Effectiveness against Elderly Frail People. Medicina (Kaunas). 2023 Jan 19;59(2):202. doi: 10.3390/medicina59020202. PMID: 36837403; PMCID: PMC9962607.
6: Kountouras J, Papaefthymiou A, Polyzos SA, Liatsos C, Tzitiridou-Chatzopoulou M, Chatzopoulos D, Vardaka E, Gialamprinou D, Kotronis G, Thavayogarajah T, Doulberis M. Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease. Dig Dis Sci. 2023 Feb;68(2):701-702. doi: 10.1007/s10620-022-07642-1. Epub 2022 Aug PMID: 35930122.
7: Kountouras J, Gialamprinou D, Kotronis G, Papaefthymiou A, Economidou E, Soteriades ES, Vardaka E, Chatzopoulos D, Tzitiridou-Chatzopoulou M, Papazoglou DD, Doulberis M. <i>Ofeleein i mi Vlaptin</i>-Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic. Medicina (Kaunas). 2022 Feb 17;58(2):309. doi: 10.3390/medicina58020309. PMID: 35208631; PMCID: PMC8874934.
8: Kountouras J, Zavos C, Chatzopoulos D. Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease. J Cell Mol Med. 2004 Jul- Sep;8(3):317-28. doi: 10.1111/j.1582-4934.2004.tb00321.x. PMID: 15491507; PMCID: PMC6740145.
9: Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res. 2008 May 1;146(1):149-58. doi: 10.1016/j.jss.2007.06.011. Epub 2007 Jul 27. PMID: 17720195.
10: Kountouras J, Zavos C, Chatzopoulos D. Apoptosis in hepatocellular carcinoma. Hepatogastroenterology. 2003 Jan-Feb;50(49):242-9. PMID: 12630032.
11: Kountouras J, Zavos C, Chatzopoulos D. Helicobacter pylori and glaucoma. Ophthalmology. 2003 Dec;110(12):2433-4; author reply 2434. doi: 10.1016/j.ophtha.2003.09.014. PMID: 14644740.
12: Kountouras J, Zavos C, Chatzopoulos D. Apoptosis in hepatitis C. J Viral Hepat. 2003 Sep;10(5):335-42. doi: 10.1046/j.1365-2893.2003.00452.x. PMID: 12969183.
13: Kountouras J, Doulberis M, Polyzos SA, Kazakos E, Vardaka E, Tzitiridou- Chatzopoulou M, Chatzopoulos D, Liatsos C, Kyriakopoulos A, Papaefthymiou A. Emerging parameters relevant to the management of antimicrobial-resistant Helicobacter pylori infection. Intern Med J. 2022 Sep;52(9):1654-1655. doi: 10.1111/imj.15872. PMID: 36100561.
14: Kountouras J, Kazakos E, Polyzos SA, Chatzopoulos D, Tzitiridou-Chatzopoulou M, Doulberis M, Papaefthymiou A, Vardaka E. GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection. Helicobacter. 2022 Jun;27(3):e12884. doi: 10.1111/hel.12884. Epub 2022 Mar 7. PMID: 35257445.
15: Kountouras J, Chatzopoulos D, Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterology. 2001 May-Jun;48(39):743-51. PMID: 11462918.
16: Kountouras J, Papaefthymiou A, Zavos C, Chatzopoulos D, Tzitiridou- Chatzopoulou M, Kavaliotis J, Tzilves D, Lazaraki G, Vardaka E, Doulberis M. Viewing the Current Puzzling Issue of COVID-19 Vaccination Safety in Older Adults. J Am Med Dir Assoc. 2023 Oct;24(10):1612-1613. doi: 10.1016/j.jamda.2023.07.010. Epub 2023 Aug 12. PMID: 37582481.
17: Kountouras J, Papaefthymiou A, Liatsos C, Tzitiridou-Chatzopoulou M, Chatzopoulos D, Gialamprinou D, Kotronis G, Vardaka E, Kazakos E, Doulberis M. Comments on “dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events”. Clin Nutr. 2022 Aug;41(8):1855-1856. doi: 10.1016/j.clnu.2022.06.015. Epub 2022 Jun 24. PMID: 35780067.
18: Kountouras J, Papaefthymiou A, Polyzos SA, Liatsos C, Tzitiridou- Chatzopoulou M, Chatzopoulos D, Vardaka E, Gialambrinou D, Kotronis G, Doulberis Potential impact of Helicobacter pylori and metabolic syndrome-related non- alcoholic fatty liver disease on cardio-cerebrovascular disease. Metabolism. 2022 Oct;135:155276. doi: 10.1016/j.metabol.2022.155276. Epub 2022 Aug 6. PMID: 35940250.
19: Kountouras J, Doulberis M, Polyzos SA, Tzitiridou M, Chatzopoulos D, Gialamprinou D, Kotronis G, Vardaka E, Liatsos C, Papaefthymiou A. A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery. Gastrointest Endosc. 2022 Dec;96(6):1088-1089. doi: 10.1016/j.gie.2022.07.003. PMID: 36404088.
20: Kountouras J, Zavos C, Chatzopoulos D, Zavos N, Boura P, Safioleas M. Locoregional immunochemotherapy in primary and metastatic liver disease: meta- analysis and review of literature. Hepatogastroenterology. 2003 Sep-Oct;50(53):1506-10. PMID: 14571774.
21: Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. Helicobacter pylori and gastro-oesophageal reflux disease. Lancet. 2006 Sep 16;368(9540):986; author reply 986-7. doi: 10.1016/S0140-6736(06)69405-1. PMID: 16980103.
22: Kountouras J, Zavos C, Chatzopoulos D. Primary open-angle glaucoma: pathophysiology and treatment. Lancet. 2004 Oct 9-15;364(9442):1311-2. doi: 10.1016/S0140-6736(04)17179-1. PMID: 15474127.
23: Kountouras J, Zavos C, Chatzopoulos D. H pylori infection and reflux oesophagitis. Gut. 2004 Jun;53(6):912. PMID: 15138222; PMCID: PMC1774071.
24: Kountouras J, Kouklakis G, Zavos C, Chatzopoulos D, Moschos J, Molyvas E, Zavos N. Apoptosis, inflammatory bowel disease and carcinogenesis: overview of international and Greek experiences. Can J Gastroenterol. 2003 Apr;17(4):249-58. doi: 10.1155/2003/527060. PMID: 12704469.
25: Kountouras J, Papaefthymiou A, Polyzos SA, Vardaka E, Kyrailidi F, Mouratidou MC, Zavos C, Kazakos E, Chatzopoulos D, Tzitiridou-Chatzopoulou M, Tzilves D, Liatsos C, Touloumtzi M, Doulberis M. Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome. J Neurogastroenterol Motil. 2023 Jul 30;29(3):403-404. doi: 10.5056/jnm23061. PMID: 37417268; PMCID: PMC10334193.
26: Kountouras J, Papaefthymiou A, Polyzos SA, Liatsos C, Vardaka E, Touloumtzi M, Tzitiridou-Chatzopoulou M, Chatzopoulos D, Doulberis M. Letter to the Editor Regarding “The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy” by Abeid et al. Obes Surg. 2022 Jun;32(6):2079-2080. doi: 10.1007/s11695-022-06045-5. Epub 2022 Apr 12.
PMID: 35412262.
27: Kyrgidis A, Kountouras J, Zavos C, Chatzopoulos D. New molecular concepts of Barrett’s esophagus: clinical implications and biomarkers. J Surg Res. 2005 May 15;125(2):189-212. doi: 10.1016/j.jss.2004.12.022. PMID: 15854673.
28: Kountouras J, Papaefthymiou A, Polyzos SA, Kazakos E, Tzilves D, Touloumtzi M, Chatzopoulos D, Tzitiridou-Chatzopoulou M, Liatsos C, Zavos C, Kavaliotis J, Kulaksiz H, Doulberis M. Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities. Aliment Pharmacol Ther. 2023 May;57(10):1186-1187. doi: 10.1111/apt.17484. PMID: 37094305.
29: Kountouras J, Zavos C, Deretzi G, Gavalas E, Chatzopoulos D, Katsinelos P, Tsiaousi E, Gagalis S, Polyzos SA, Venizelos I. Potential implications of Helicobacter pylori-related neutrophil-activating protein. World J Gastroenterol. 2012 Feb 7;18(5):489-90. doi: 10.3748/wjg.v18.i5.489. PMID: 22346256; PMCID: PMC3270508.
30: Kountouras J, Zavos C, Chatzopoulos D. Therapy for colorectal cancer. N Engl J Med. 2005 Apr 28;352(17):1820-1; author reply 1822. doi:
10.1056/NEJM200504283521720. Erratum in: N Engl J Med. 2005 Jun 16:352(24):2563. PMID: 15858197.
31: Kountouras J, Zavos C, Deretzi G, Polyzos SA, Gavalas E, Tsiaousi E, Giartza-Taxidou E, Chatzopoulos D, Michael S, Tsarouchas G. Neuroprotection in glaucoma: is there a future role of Helicobacter pylori eradication? Exp Eye Res. 2011 May;92(5):436-8. doi: 10.1016/j.exer.2011.02.017. Epub 2011 Mar 4. PMID: 21377461.
32: Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology. 2006 Mar 28;66(6):938-40. doi: 10.1212/01.wnl.0000203644.68059.5f. PMID: 16567719.
33: Kountouras J, Mylopoulos N, Boura P, Bessas C, Chatzopoulos D, Venizelos J, Zavos C. Relationship between Helicobacter pylori infection and glaucoma. Ophthalmology. 2001 Mar;108(3):599-604. doi: 10.1016/s0161-6420(00)00598-4. PMID: 11237916.
34: Kountouras J, Zavos C, Polyzos SA, Deretzi G, Vardaka E, Giartza-Taxidou E, Katsinelos P, Rapti E, Chatzopoulos D, Tzilves D, Stergiopoulos C, Christodoulou Helicobacter pylori infection and Parkinson’s disease: apoptosis as an underlying common contributor. Eur J Neurol. 2012 Jun;19(6):e56. doi: 10.1111/j.1468-1331.2012.03695.x. PMID: 22577753.
35: Kountouras J, Zavos C, Chatzopoulos D. New concepts of molecular biology on gastric carcinogenesis. Hepatogastroenterology. 2005 Jul-Aug;52(64):1305-12. PMID: 16001683.
36: Kountouras J, Gavalas E, Boziki M, Zavos C, Deretzi G, Grigoriadis N, Tsiaousi E, Katsinelos P, Chatzopoulos D, Tzilves D, Kouklakis G. High prevalence of dementia and cognitive impairment in indigenous Australians. Neurology. 2009 Aug 11;73(6):487; author reply 487-8. doi: 10.1212/WNL.0b013e3181ab9a93. PMID: 19667328.
37: Kountouras J, Zavos C, Touloumis L, Chatzopoulos D. Oral furosemide-induced natriuresis: a potential method for identifying cirrhotic patients with refractory ascites. Liver Int. 2010 Oct;30(9):1395; author reply 1395-6. doi: 10.1111/j.1478-3231.2010.02329.x. PMID: 20731771.
38: Kountouras J, Zavos C, Chatzopoulos D, Polyzos SA, Deretzi G, Simeonidou C, Grigoriadis N, Vardaka E, Kountouras C, Loli E, Moschos J, Kouklakis G, Katsinelos P. Letter: low risk of colorectal cancer in a Greek cohort of inflammatory bowel disease patients. Aliment Pharmacol Ther. 2014 May;39(9):1001-2. doi: 10.1111/apt.12689. PMID: 24689353.
39: Kountouras J, Zavos C, Chatzopoulos D. Salt intake and Helicobacter pylori infection. J Hypertens. 2004 Dec;22(12):2397. doi: 10.1097/00004872-200412000-00023. PMID: 15614036. 40: Moschos JM, Kouklakis G, Vradelis S, Zezos P, Pitiakoudis M, Chatzopoulos D,
Zavos C, Kountouras J. Patients with established gastro-esophageal reflux disease might benefit from <i>Helicobacter pylori</i> eradication. Ann Gastroenterol. 2014;27(4):352-356. PMID: 25330805; PMCID: PMC4188932.
41: Zavos C, Kountouras J, Zavos N, Chatzopoulos D. Inhibition of tumour necrosis factor-alpha in patients with chronic hepatitis C infection. Clin Rheumatol. 2007 Feb;26(2):283. doi: 10.1007/s10067-006-0437-5. Epub 2006 Sep 27. PMID: 17003955.
42: Kountouras J, Zavos C, Chatzopoulos D. The role of gastric Helicobacter pylori infection in laryngopharyngeal reflux disease. Otolaryngol Head Neck Surg. 2007 Feb;136(2):334; author reply 334-5. doi: 10.1016/j.otohns.2006.10.026. PMID: 17275574.
43: Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Grigoriadis N, Tsolaki M, Chatzopoulos D, Katsinelos P, Tzilves D, Zabouri A, Michailidou I. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer’s disease. Int J Neurosci. 2009;119(6):765-77. doi: 10.1080/00207450902782083. PMID: 19326283.
44: Kountouras J, Zavos C, Gavalas E, Boziki M, Chatzopoulos D, Katsinelos P. Normal-tension glaucoma and Alzheimer’s disease: Helicobacter pylori as a possible common underlying risk factor. Med Hypotheses. 2007;68(1):228-9. doi: 10.1016/j.mehy.2006.07.008. Epub 2006 Sep 15. PMID: 16978795.
45: Kountouras J, Boziki M, Gavalas E, Zavos C, Grigoriadis N, Deretzi G, Tzilves D, Katsinelos P, Tsolaki M, Chatzopoulos D, Venizelos I. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease. J Neurol. 2009 May;256(5):758-67. doi: 10.1007/s00415-009-5011-z. Epub 2009 Feb PMID: 19240960.
46: Kountouras J, Chatzopoulos D, Zavos C, Polyzos SA, Giartza-Taxidou E, Vardaka E, Molyvas E, Kouklakis G, Tsiaousi E, Klonizakis P. Helicobacter pylori infection might contribute to esophageal adenocarcinoma progress in subpopulations with gastroesophageal reflux disease and Barrett’s esophagus. Helicobacter. 2012 Oct;17(5):402-3. doi: 10.1111/j.1523-5378.2012.00963.x. Epub
2012 May 27. PMID: 22967125.
47: Kountouras J, Tsolaki M, Boziki M, Gavalas E, Zavos C, Stergiopoulos C, Kapetanakis N, Chatzopoulos D, Venizelos I. Association between Helicobacter pylori infection and mild cognitive impairment. Eur J Neurol. 2007 Sep;14(9):976-82. doi: 10.1111/j.1468-1331.2007.01827.x. PMID: 17718688.
48: Kountouras J, Gavalas E, Deretzi G, Boziki M, Zavos C, Chatzopoulos D, Katsinelos P, Giartza-Taxidou E, Grigoriadis N, Venizelos I. Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica. Mult Scler. 2010 Mar;16(3):376-7; author reply 378-9. doi: 10.1177/1352458509360550. PMID: 20203152.
49: Kountouras J, Chatzopoulos D, Zavos C, Deretzi G, Polyzos SA, Gavalas E, Klonizakis P, Vardaka E, Katsinelos P, Stergiopoulos C, Moschos J, Giartza- Taxidou E. Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett’s esophagus, dysplasia, and adenocarcinoma. Surg Endosc. 2012 Jan;26(1):283-4. doi: 10.1007/s00464-011-1864-1. PMID: 21858571.
50: Kountouras J, Zavos C, Chatzopoulos D. Induction of apoptosis as a proposed pathophysiological link between glaucoma and Helicobacter pylori infection. Med Hypotheses. 2004;62(3):378-81. doi: 10.1016/j.mehy.2003.11.013. PMID: 14975507.
51: Kountouras J, Zavos C, Chatzopoulos D. Body mass index and socioeconomic status measured in adolescence, country of origin, and the incidence of gastroesophageal adenocarcinoma in a cohort of 1 million men. Cancer. 2014 Mar 1;120(5):768. doi: 10.1002/cncr.28489. Epub 2013 Nov 18. PMID: 24249523.
52: Kountouras J, Deretzi G, Zavos C, Karatzoglou P, Touloumis L, Nicolaides T, Chatzopoulos D, Venizelos I. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2005 Feb;12(2):139-43. doi: 10.1111/j.1468-1331.2004.00977.x. PMID: 15679702.
53: Kountouras J, Zavos C, Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J Cell Mol Med. 2005 Jan- Mar;9(1):196-207. doi: 10.1111/j.1582-4934.2005.tb00349.x. PMID: 15784177; PMCID: PMC6741421.
54: Kountouras J, Mylopoulos N, Chatzopoulos D, Zavos C, Boura P, Konstas AG, Venizelos J. Eradication of Helicobacter pylori may be beneficial in the management of chronic open-angle glaucoma. Arch Intern Med. 2002 Jun 10;162(11):1237-44. doi: 10.1001/archinte.162.11.1237. PMID: 12038941.
55: Kountouras J, Patsiaoura K, Zavos C, Chatzopoulos D, Katsinelos P, Tantsi N, Polyzos SA, Giouleme O, Gigi E, Deretzi G, Simeonidou C, Grigoriadis N, Boura P. Letter: apoptosis and hepatic fibrosis in chronic hepatitis B. Aliment Pharmacol Ther. 2014 May;39(9):996. doi: 10.1111/apt.12643. PMID: 24689347.
56: Kountouras J, Zavos C, Chatzopoulos D. Apoptosis and autoimmunity as proposed pathogenetic links between Helicobacter pylori infection and idiopathic achalasia. Med Hypotheses. 2004;63(4):624-9. doi: 10.1016/j.mehy.2004.04.003. PMID: 15325006.
57: Kountouras J, Chatzopoulos D, Zavos C, Boura P, Venizelos J, Kalis A. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome. Hepatogastroenterology. 2002 Jan-Feb;49(43):193-7. PMID: 11941952.
58: Kountouras J, Chatzopoulos D, Zavos C. Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro- oesophageal reflux disease and Barrett’s oesophagus. Med Hypotheses. 2007;68(5):1174-5. doi: 10.1016/j.mehy.2006.11.020. Epub 2006 Dec 29. PMID: 17196756.
59: Kountouras J, Gavalas E, Zavos C, Stergiopoulos C, Chatzopoulos D, Kapetanakis N, Gisakis D. Alzheimer’s disease and Helicobacter pylori infection: Defective immune regulation and apoptosis as proposed common links. Med Hypotheses. 2007;68(2):378-88. doi: 10.1016/j.mehy.2006.06.052. Epub 2006 Sep PMID: 16979298.
60: Kountouras J, Zavos C, Chatzopoulos D. Anti-tumor necrosis factor therapy for ulcerative colitis. Gastroenterology. 2005 Sep;129(3):1138-9. doi: 10.1053/j.gastro.2005.07.047. PMID: 16143158.
61: Kountouras J, Zavos C, Chatzopoulos D. Ocular and systemic side effects of latanoprost. Eye (Lond). 2005 Jul;19(7):804-5; author reply 805-6. doi: 10.1038/sj.eye.6701634. PMID: 15359267.
62: Kountouras J, Zavos C, Chatzopoulos D. Risk of extra-oesophageal malignancies in Barrett’s oesophagus. Scand J Gastroenterol. 2004 Dec;39(12):1314. doi: 10.1080/00365520410011452. PMID: 15743014.
63: Kountouras J, Zavos C, Chatzopoulos D. Less H. pylori not necessarily more GERD. Am J Gastroenterol. 2005 Jan;100(1):249-50. doi:
10.1111/j.1572-0241.2005.41277_4.x. PMID: 15654809.
64: Lazaraki G, Kountouras J, Metallidis S, Dokas S, Bakaloudis T, Chatzopoulos D, Gavalas E, Zavos C. Single use of fentanyl in colonoscopy is safe and effective and significantly shortens recovery time. Surg Endosc. 2007 Sep;21(9):1631-6. doi: 10.1007/s00464-007-9215-y. Epub 2007 Feb 16. PMID: 17762959.
65: Kountouras J, Zavos C, Chatzopoulos D. Apoptotic and anti-angiogenic strategies in liver and gastrointestinal malignancies. J Surg Oncol. 2005 Jun 15;90(4):249-59. doi: 10.1002/jso.20254. PMID: 15906369.
66: Kountouras J, Zavos C, Chatzopoulos D, Romiopoulos I, Polyzos SA, Kapetanakis N, Tsiaousi E, Vardaka E, Deretzi G, Tsarouchas G, Katsinelos P. Letter: is Helicobacter pylori behind Barrett’s oesophagus and colorectal neoplasms? Aliment Pharmacol Ther. 2013 Apr;37(8):837. doi: 10.1111/apt.12247. PMID: 23496313.
67: Kountouras J, Zavos C, Chatzopoulos D. Pathogenetic links between colorectal neoplasia and Barrett’s esophagus. Gastrointest Endosc. 2006 Aug;64(2):298. doi: 10.1016/j.gie.2006.04.002. PMID: 16860098.
68: Lazaraki G, Kountouras J, Metallidis S, Vrettou E, Tzioufa V, Germanidis G, Chatzopoulos D, Zavos C, Giannoulis K, Nikolaidis P. Helicobacter pylori infection upregulates endothelial nitric oxide synthase expression and induces angiogenesis in gastric mucosa of dyspeptic patients. Eur J Gastroenterol Hepatol. 2008 May;20(5):441-9. doi: 10.1097/MEG.0b013e3282f4c35a. PMID: 18403947.
69: Kountouras J, Mylopoulos N, Konstas AG, Zavos C, Chatzopoulos D, Boukla A. Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol. 2003 Nov;241(11):884-90. doi: 10.1007/s00417-003-0779-5. Epub 2003 Oct 24. PMID: 14576945.
70: Kountouras J, Zavos C, Chatzopoulos D. Autoimmune pancreatitis, Helicobacter pylori infection, and apoptosis: a proposed relationship. Pancreas. 2005 Mar;30(2):192-3. doi: 10.1097/01.mpa.0000151576.91790.f8. PMID: 15714146.
71: Papagoras C, Kountouras J, Brilakis S, Chatzopoulos D, Zavos C, Topalidis A. Rheumatic-like syndrome as a symptom of underlying gastric cancer. Clin Rheumatol. 2007 Jun;26(6):1029-31. doi: 10.1007/s10067-006-0268-4. Epub 2006 Mar PMID: 16572285.
72: Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. Molecular mechanisms associated with aggressiveness of alpha-fetoprotein-positive gastric cancer. Hepatogastroenterology. 2007 Mar;54(74):329-30. PMID: 17523267.
73: Gavalas E, Kountouras J, Stergiopoulos C, Zavos C, Gisakis D, Nikolaidis N, Giouleme O, Chatzopoulos D, Kapetanakis N. Efficacy and safety of infliximab in steroid-dependent ulcerative colitis patients. Hepatogastroenterology. 2007 Jun;54(76):1074-9. PMID: 17629042.
74: Kountouras J, Kazakos E, Kyrailidi F, Polyzos SA, Zavos C, Arapoglou S, Boziki M, Mouratidou MC, Tzitiridou-Chatzopoulou M, Chatzopoulos D, Doulberis M, Papaefthymiou A, Vardaka E. Innate immunity and nonalcoholic fatty liver disease. Ann Gastroenterol. 2023 May-Jun;36(3):244-256. doi: 10.20524/aog.2023.0793. Epub 2023 Apr 8. PMID: 37144011; PMCID: PMC10152810.
75: Kountouras J, Zavos C, Chatzopoulos D. Induction of interleukin-8 expression by Helicobacter pylori infection in patients with endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol. 2004 Dec;99(12):2500-1; author reply 2501-2. doi: 10.1111/j.1572-0241.2004.41389_3.x. PMID: 15571602.
76: Kountouras J, Zavos C, Chatzopoulos D. Apoptosis and apoptosis-related proteins in inflammatory bowel disease. Apoptosis. 2004 Sep;9(5):657-8; author reply 659. doi: 10.1023/b:appt.0000038058.83946.40. PMID: 15337851.
77: Zavos C, Kountouras J, Chatzopoulos D, Katsinelos P. Losing weight by defaecating at night theory: The gastroenterologists’ perspective. Med Hypotheses. 2007;68(2):467-8. doi: 10.1016/j.mehy.2006.08.006. Epub 2006 Sep 27. PMID: 17008026.
78: Kountouras J, Zavos C, Chatzopoulos D. Helicobacter pylori infection and the risk for coronary artery disease. Saudi Med J. 2004 May;25(5):679-80, author reply 680-1. PMID: 15138546. 79: Kountouras J, Zavos C, Chatzopoulos D. Apoptotic markers in assessing
patients with chronic hepatitis C. Gastroenterology. 2005 May;128(5):1531-2; author reply 1532-3. doi: 10.1053/j.gastro.2005.03.058. PMID: 15887146.
80: Kountouras J, Zavos C, Chatzopoulos D. Re: “Prognostic significance of Bcl- xL in human hepatocellular carcinoma”. Surgery. 2005 Feb;137(2):265-6. doi: 10.1016/j.surg.2004.06.038. PMID: 15674216.
81: Zavos C, Kountouras J, Chatzopoulos D. Helicobacter pylori infection in dialysis patients undergoing kidney transplantation. Saudi J Kidney Dis Transpl. 2006 Dec;17(4):579-80. PMID: 17186698.
